ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2017

Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors.

Renata Ferrarotto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.